Cargando…

The anti-tumour effects of zoledronic acid

Bone is the most common site for metastasis in patients with solid tumours. Bisphosphonates are an effective treatment for preventing skeletal related events and preserving quality of life in these patients. Zoledronic acid (ZA) is the most potent osteoclast inhibitor and is licensed for the treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zekri, Jamal, Mansour, Maged, Karim, Syed Mustafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723416/ https://www.ncbi.nlm.nih.gov/pubmed/26909294 http://dx.doi.org/10.1016/j.jbo.2013.12.001

Ejemplares similares

Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions
por: George, Christopher N., et al.
Publicado: (2020)

Chemotherapy for small cell lung cancer: a comprehensive review
por: Karim, Syed Mustafa, et al.
Publicado: (2012)

Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells
por: Insalaco, Lavinia, et al.
Publicado: (2012)

Dosing of zoledronic acid with its anti-tumor effects in breast cancer
por: Zhao, Xinmin, et al.
Publicado: (2015)

Breaking Cancer Bad News to Patients With Cancer: A Comprehensive Perspective of Patients, Their Relatives, and the Public—Example From a Middle Eastern Country
por: Zekri, Jamal, et al.
Publicado: (2016)

The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
por: Coleman, R E, et al.
Publicado: (2010)

The differential anti-tumour effects of zoledronic acid in breast cancer – evidence for a role of the activin signaling pathway
por: Wilson, Caroline, et al.
Publicado: (2015)

Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma
por: Veltman, J D, et al.
Publicado: (2010)

Use of zoledronic acid in the treatment of Paget’s disease
por: Seton, Margaret, et al.
Publicado: (2007)

Zoledronic acid in the management of metastatic bone disease
por: Polascik, Thomas J, et al.
Publicado: (2008)

Role of zoledronic acid in the prevention and treatment of osteoporosis
por: Räkel, Agnès, et al.
Publicado: (2011)

Zoledronic acid infusion for prevention and treatment of osteoporosis
por: Sunyecz, John A
Publicado: (2010)

Human stromal cells are required for an anti-breast cancer effect of zoledronic acid
por: Nienhuis, Hilde H., et al.
Publicado: (2015)

Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture
por: Chapurlat, Roland D
Publicado: (2009)

Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect
por: Lewiecki, E Michael
Publicado: (2010)

Cost-Effectiveness of Sequential Teriparatide/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
por: You, Ruxu, et al.
Publicado: (2022)

Cost-Effectiveness of Sequential Denosumab/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
por: You, Ruxu, et al.
Publicado: (2022)

Once-yearly zoledronic acid in hip fracture prevention
por: Demontiero, Oddom, et al.
Publicado: (2009)

Management of osteoporosis in the aging male: Focus on zoledronic acid
por: Piper, Paul K, et al.
Publicado: (2009)

The evolving role of zoledronic acid in early breast cancer
por: Gnant, Michael
Publicado: (2009)

Zoledronic acid is an effective radiosensitizer in the treatment of osteosarcoma
por: Kim, Eun Ho, et al.
Publicado: (2016)

Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
por: Coscia, Marta, et al.
Publicado: (2010)

Cryoablation combined with zoledronic acid in comparison with cryoablation and zoledronic acid alone in the treatment of painful bone metastases
por: LI, FENQIANG, et al.
Publicado: (2014)

Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer
por: El Saghir, Nagi S, et al.
Publicado: (2005)

Biological Effects of Anti-RANKL Antibody and Zoledronic Acid on Growth and Tooth Eruption in Growing Mice
por: Isawa, Motoki, et al.
Publicado: (2019)

Clinical effect of Zoledronic Acid in the treatment of Senile Osteoporosis
por: Kong, Li, et al.
Publicado: (2020)

Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
por: Dalle Carbonare, Luca, et al.
Publicado: (2010)

Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis
por: Serefoglu, Ege Can, et al.
Publicado: (2010)

Safety of Intravitreal Zoledronic Acid, an Anti-angiogenic Bisphosphonate, in a Rat Model
por: Nourinia, Ramin, et al.
Publicado: (2014)

Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment?
por: Steinman, Richard A, et al.
Publicado: (2012)

Zoledronic Acid–Induced Interface Dermatitis
por: Succaria, Farah, et al.
Publicado: (2015)

Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer
por: Duivenvoorden, W C M, et al.
Publicado: (2007)

Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone
por: Giveon, Sharon, et al.
Publicado: (2023)

Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2(+) T cells compared with the aminobisphosphonate drug zoledronic acid
por: Fenn, J, et al.
Publicado: (2022)

Time from last chemotherapy to death and its correlation with the end of life care in a referral hospital
por: Karim, Syed Mustafa, et al.
Publicado: (2015)

Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis
por: Ringe, Johann D
Publicado: (2010)

Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid
por: Aft, Rebecca
Publicado: (2012)

Minimally effective concentration of zoledronic acid to suppress osteoclasts in vitro
por: Li, Pengfei, et al.
Publicado: (2018)

Zoledronic acid plus methylprednisolone versus zoledronic acid or placebo in symptomatic knee osteoarthritis: a randomized controlled trial
por: Cai, Guoqi, et al.
Publicado: (2019)

Targeting of colorectal cancer organoids with zoledronic acid conjugated to the anti-EGFR antibody cetuximab
por: Benelli, Roberto, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fi9dafea0sqbr4vrtqm9gbhhhg